Literature DB >> 11807786

Inhibition of tumor growth and metastatic spreading by overexpression of inter-alpha-trypsin inhibitor family chains.

Sébastien Paris, Richard Sesboüé, Bertrand Delpech, Claude Chauzy, Luc Thiberville, Jean-Pierre Martin, Thierry Frébourg, Maryam Diarra-Mehrpour.   

Abstract

The inter-alpha trypsin inhibitor (ITI) family is a group of proteins built up from different combinations of I light chain (ITI-L) and 3 highly homologous heavy chains (ITI-HI, -H2 and -H3). To investigate a potential role of the ITI family chains in cancer and metastasis spreading, we engineered human H460M cell lines expressing both the green fluorescent protein (GFP) and one of these chains. These clones were subcutaneously injected in athymic nude mice, and lung metastasis number and primary tumor weight were determined after 28 days. Expression of the ITI-L chain considerably decreased tumor weight and fluorescent lung metastasis number. ITI-HI and ITI-H3 chain expression induced a significant decrease of metastasis number, whereas no decrease of tumor weight could be detected. In vitro, ITI-L expression significantly decreased chemotaxis and ITI-HI and ITI-H3 expression increased cell attachment. These results argue for the antitumoral or antimetastatic properties of ITI-L, -HI and -H3 chains. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807786     DOI: 10.1002/ijc.10120

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

Authors:  Roberta Caruso; Francesco Pallone; Daniele Fina; Valentina Gioia; Ilaria Peluso; Flavio Caprioli; Carmine Stolfi; Alessandra Perfetti; Luigi Giusto Spagnoli; Giampiero Palmieri; Thomas T Macdonald; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.

Authors:  Ken Sasaki; Hiroshi Kurahara; Eric D Young; Shoji Natsugoe; Asami Ijichi; Tomoo Iwakuma; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2017-03-13       Impact factor: 5.150

Review 3.  Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors.

Authors:  Ulrich H Weidle; Fabian Birzele; Georg Tiefenthaler
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

4.  ITIH3 is a potential biomarker for early detection of gastric cancer.

Authors:  Poh Kuan Chong; Huiyin Lee; Jianbiao Zhou; Shaw-Cheng Liu; Marie Chiew Shia Loh; Ting Ting Wang; Siew Pang Chan; Duane T Smoot; Hassan Ashktorab; Jimmy Bok Yan So; Khong Hee Lim; Khay Guan Yeoh; Yoon Pin Lim
Journal:  J Proteome Res       Date:  2010-07-02       Impact factor: 4.466

5.  Cytotoxic capability and the associated proteomic profile of cell-free coelomic fluid extracts from the edible sea cucumber Holothuria tubulosa on HepG2 liver cancer cells.

Authors:  Claudio Luparello; Rossella Branni; Giulia Abruscato; Valentina Lazzara; Laszlo Drahos; Vincenzo Arizza; Manuela Mauro; Vita Di Stefano; Mirella Vazzana
Journal:  EXCLI J       Date:  2022-04-25       Impact factor: 4.022

6.  [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].

Authors:  J Veeck; E Breuer; M Rose; M Chorovicer; A Naami; N Bektas; S Alkaya; S von Serényi; F Horn; A Hartmann; R Knüchel; E Dahl
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

7.  Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.

Authors:  Xuguang Zhu; Keisuke Enomoto; Li Zhao; Yuelin J Zhu; Mark C Willingham; Paul Meltzer; Jun Qi; Sheue-Yann Cheng
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

8.  Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.

Authors:  Cong Mai; Jing-jing Zhao; Xiao-feng Tang; Wei Wang; Ke Pan; Qiu-zhong Pan; Xiao-fei Zhang; Shan-shan Jiang; Bai-wei Zhao; Yuan-fang Li; Jian-chuan Xia; Zhi-wei Zhou
Journal:  Med Oncol       Date:  2014-06-10       Impact factor: 3.064

9.  The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.

Authors:  Michael Rose; Erik Noetzel; Jennifer Kistermann; Julian Eschenbruch; Sandra Rushrush; Lin Gan; Ruth Knüchel; Nadine T Gaisa; Edgar Dahl
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

10.  Identification of differentially expressed serum proteins in gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Sartaj Ahmad Mir; Santosh Renuse; Srikanth S Manda; Sneha M Pinto; Vinuth N Puttamallesh; Hitendra Singh Solanki; H C Manju; Nazia Syed; Rakesh Sharma; Rita Christopher; M Vijayakumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha V Kumar; Aditi Chatterjee; Akhilesh Pandey; Harsha Gowda
Journal:  J Proteomics       Date:  2015-05-05       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.